Trials / Completed
CompletedNCT06079645
Lichen Sclerosus - Treatment With Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Technique)
Triamcinolone Acetonide Injections Compared With Micro Injections (MMP Technique) of Triamcinolone Acetonide for the Treatment of Female Genital Lichen Sclerosus and Atrophic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Clinica Dermatologica Arbache ltda · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research is about a genital disease known as Lichem Sclerosus and Atrophic. It mainly affects women over 18 years of age. The treatment will involve injections of a medicine that contains cortisone, using two different methods: with a syringe and a needle or with a tattoo machine. Before and after treatment, they will see if women feel pain, itching, burning, scratching or difficulty having sexual intercourse.
Detailed description
There is evidence that injectable triamcinolone has an effect on reducing the symptoms of lichen sclerosus and atrophic. After randomizing the vulva, the vulva will be anesthetized with lidocaine infiltrations. After 15 minutes, interventions will begin. Triamcinolone will be injected using two different techniques: syringes \& needles in one side and with tattoo machine (MMP technique) in other side. The outcomes will be evaluated according to the criteria of pain, itching, burning, itching and difficulty in sexual penetration
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Infiltration of triamcinolone acetonide (2mg/ml) through syringes and needles | Infiltration of triamcinolone acetonide (2mg/ml) through syringes and needles |
| PROCEDURE | Infiltration of triamcinolone acetonide (40 mg/ml) with needles | Infiltration of triamcinolone acetonide (40 mg/ml) through needles of tattoo machine |
Timeline
- Start date
- 2023-10-20
- Primary completion
- 2025-05-14
- Completion
- 2025-06-14
- First posted
- 2023-10-12
- Last updated
- 2026-01-21
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT06079645. Inclusion in this directory is not an endorsement.